Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Feb 27, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Supernus Pharmaceuticals, Inc.
| 3.89K |
—
|
—
| +4.62% | 87.94K |
Feb 23
| |||||||
Supernus Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 22
| |||||||
Supernus Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 23
| |||||||
Supernus Pharmaceuticals, Inc.
| 3.88K |
—
|
—
| +4.84% | 84.06K |
Feb 22
| |||||||
Supernus Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 22
| |||||||
Supernus Pharmaceuticals, Inc.
| 4.22K |
—
|
—
| +5.56% | 80.17K |
Feb 19
| |||||||
Supernus Pharmaceuticals, Inc.
| 15K |
$12.98 | $194,700.00 | +24.61% | 75.95K |
Aug 11
| |||||||
Supernus Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 19
| |||||||
Supernus Pharmaceuticals, Inc.
| 5.21K |
$23.99 | $125,011.89 | +9.35% | 60.95K |
Feb 21
| |||||||
Supernus Pharmaceuticals, Inc.
| 10K |
$9.13 | $91,300.00 | +21.86% | 55.74K |
Jun 20
| |||||||
Supernus Pharmaceuticals Inc
| 10K |
$9.13 | $91,300.00 | +27.98% | 45.74K |
Apr 25
| |||||||
Supernus Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
|
Feb 22
| |||||||
Supernus Pharmaceuticals Inc
| 16.18K |
$8.52 | $137,806.48 | +82.70% | 35.74K |
Aug 20
| |||||||
Supernus Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
|
Feb 22
| |||||||
Aradigm Corp
|
0
|
—
|
—
|
—
|
0
|
Mar 22
| |||||||
Supernus Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
|
Feb 23
| |||||||
Supernus Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
|
Jun 13
| |||||||
Aradigm Corp
|
0
|
—
|
—
|
—
|
0
|
Jun 1
| |||||||
Supernus Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
|
Feb 24
| |||||||
Aradigm Corp
|
0
|
—
|
—
|
—
|
0
|
Jun 9
| |||||||
Supernus Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
|
Mar 1
| |||||||
Aradigm Corp
|
0
|
—
|
—
|
—
|
0
|
Nov 12
| |||||||
Supernus Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
|
Mar 3
| |||||||
Supernus Pharmaceuticals Inc
| 2.19K |
$4.24 | $9,277.12 | +12.59% | 19.56K |
Dec 16
| |||||||
Aradigm Corp
|
0
|
—
|
—
|
—
|
0
|
Apr 18
| |||||||
Supernus Pharmaceuticals Inc
| 2.19K |
$4.24 | $9,272.88 | +14.40% | 17.38K |
Dec 12 - Jan 21
| |||||||
Aradigm Corp
| 100K |
$0.15 | $15,000.00 | +24.89% | 501.7K |
May 22
| |||||||
Supernus Pharmaceuticals Inc
| 3K |
$5.50 | $16,499.70 | +24.61% | 15.19K |
Mar 21
| |||||||
Supernus Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
|
Feb 5
| |||||||
Supernus Pharmaceuticals Inc
| 2.19K |
$4.24 | $9,277.12 | +21.88% | 12.19K |
Dec 14
| |||||||
Supernus Pharmaceuticals Inc
| 7K |
$8.14 | $56,980.00 | +233.33% | 10K |
Dec 4
| |||||||
Aradigm Corp
| 100K |
—
|
—
| +33.15% | 401.7K |
May 25
| |||||||
Supernus Pharmaceuticals Inc
| 3K |
$5.00 | $15,000.00 |
∞
| 3K |
May 4
| |||||||
Supernus Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
| ||||||||
Aradigm Corp
| 78.95K |
—
|
—
| +35.44% | 301.7K |
May 26
| |||||||
Aradigm Corp
| 125K |
—
|
—
| +127.88% | 222.75K |
May 14
| |||||||
Aradigm Corp
| 93.75K |
—
|
—
| +2,343.75% | 97.75K |
May 15
| |||||||
Aradigm Corp
| 93.75K |
—
|
—
| +2,343.75% | 97.75K |
May 15
| |||||||
Aradigm Corp
|
0
|
—
|
—
|
—
|
0
|
May 15
| |||||||
Aradigm Corp
|
0
|
—
|
—
|
—
|
0
|
Jun 20
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. |
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.